Companion Animal Postoperative Pain Management Therapeutics Market Size, Share & Trends Analysis Report By Animal, By Product (NSAIDs, Anesthetics), By Route of Administration, By End-use, By Region, And Segment Forecasts, 2025 - 2030
This report can be delivered to the clients within 3 Business Days
Companion Animal Postoperative Pain Management Therapeutics Market Growth & Trends
The global companion animal postoperative pain management therapeutics market size is expected treach USD 671.4 million by 2030, registering tgrow at a CAGR of 10.9% from 2025 t2030 according ta new report by Grand View Research, Inc. Increasing number of surgeries in companion animals is driving the demand for postoperative pain management drugs.
Increasing companion healthcare expenditure and concerns among pet owners is further propelling the market growth. According tThe American Pet Products Association report 2024, the overall spending in U.S. pet industry has increased during forecast period. Significant rise in animal insurance policies helps pet owners take proper care of their pets. For instance, in 2024, maximum pet insurance claims were reported for chronic diseases such as arthritis in pets in U.S. According ta report by the Department of Clinical Veterinary Science and the Pet Food Institute.
Companion Animal Postoperative Pain Management Therapeutics Market Report Highlights
Companion Animal Postoperative Pain Management Therapeutics Market Growth & Trends
The global companion animal postoperative pain management therapeutics market size is expected treach USD 671.4 million by 2030, registering tgrow at a CAGR of 10.9% from 2025 t2030 according ta new report by Grand View Research, Inc. Increasing number of surgeries in companion animals is driving the demand for postoperative pain management drugs.
Increasing companion healthcare expenditure and concerns among pet owners is further propelling the market growth. According tThe American Pet Products Association report 2024, the overall spending in U.S. pet industry has increased during forecast period. Significant rise in animal insurance policies helps pet owners take proper care of their pets. For instance, in 2024, maximum pet insurance claims were reported for chronic diseases such as arthritis in pets in U.S. According ta report by the Department of Clinical Veterinary Science and the Pet Food Institute.
Companion Animal Postoperative Pain Management Therapeutics Market Report Highlights
- Dogs accounted for 46.8% of revenue share in 2024. This can be attributed tthe high number of surgical procedures performed on dogs, particularly orthopedic surgeries and dental procedures.
- NSAIDs held the largest market share of 42.4% in 2024. This dominance is due tthe widespread use of NSAIDs in managing pain and inflammation in pets, particularly after surgeries. NSAIDs are favored for their effectiveness in reducing pain, swelling, and fever, making them a go-tchoice for veterinarians.
- The oral segment held 86.6% of the market share in 2024 attributed tthe ease of administration and the preference for oral medications among pet owners. Oral pain management drugs, such as NSAIDs and opioids, are commonly prescribed for postoperative care in companion animals.
- The veterinary hospitals and clinics segment dominated the market in 2024 due tthe high volume of surgical procedures performed in these settings, which necessitates effective pain management solutions.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Animal
1.2.2. Product
1.2.3. Route of Administration
1.2.4. End Use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
CHAPTER 3. COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
CHAPTER 4. COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET: ANIMAL BUSINESS ANALYSIS
4.1. Animal Market Share, 2024 & 2030
4.2. Animal Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Animal, 2018 to 2030 (USD Million)
4.4. Dogs
4.4.1. Dogs postoperative pain management therapeutics market, 2018 - 2030 (USD Million)
4.5. Cats
4.5.1. Cats postoperative pain management therapeutics market, 2018 - 2030 (USD Million)
4.6. Horses
4.6.1. Horses postoperative pain management therapeutics market, 2018 - 2030 (USD Million)
4.7. Other companions
4.7.1. Other companions postoperative pain management therapeutics market, 2018 - 2030 (USD Million)
CHAPTER 5. COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET: PRODUCT BUSINESS ANALYSIS
5.1. Product Market Share, 2024 & 2030
5.2. Product Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. NSAIDs
5.4.1. NSAIDs market, 2018 - 2030 (USD Million)
5.5. Anesthetics
5.5.1. Anesthetics market, 2018 - 2030 (USD Million)
5.6. Opioids
5.6.1. Opioids market, 2018 - 2030 (USD Million)
5.7. Others
5.7.1. Other market, 2018 - 2030 (USD Million)
CHAPTER 6. COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET: ROUTE OF ADMINISTRATION BUSINESS ANALYSIS
6.1. Route of Administration Market Share, 2024 & 2030
6.2. Route of Administration Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
6.4. Oral
6.4.1. Oral market, 2018 - 2030 (USD Million)
6.5. Injectable
6.5.1. Injectable market, 2018 - 2030 (USD Million)
CHAPTER 7. COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET: END USE BUSINESS ANALYSIS
7.1. End Use Market Share, 2024 & 2030
7.2. End Use Segment Dashboard
7.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
7.4. Retail
7.4.1. Retail market, 2018 - 2030 (USD Million)
7.5. E-commerce
7.5.1. E-commerce market, 2018 - 2030 (USD Million)
7.6. Veterinary hospitals & clinics
7.6.1. Veterinary hospitals & clinics market, 2018 - 2030 (USD Million)
CHAPTER 8. COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS BY ANIMAL, PRODUCT, ROUTE OF ADMINISTRATION, AND END USE
8.1. Regional Market Share Analysis, 2024 & 2030
8.2. Regional Market Dashboard
8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
8.4. North America
8.4.1. North America companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.4.2. U.S.
8.4.2.1. Key country dynamics
8.4.2.2. Regulatory framework
8.4.2.3. Competitive insights
8.4.2.4. U.S. companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.4.3. Canada
8.4.3.1. Key country dynamics
8.4.3.2. Regulatory framework
8.4.3.3. Competitive insights
8.4.3.4. Canada companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.4.4. Mexico
8.4.4.1. Key country dynamics
8.4.4.2. Regulatory framework
8.4.4.3. Competitive insights
8.4.4.4. Mexico companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.5. Europe
8.5.1. Europe companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.5.2. UK
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework
8.5.2.3. Competitive insights
8.5.2.4. UK companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.5.3. Germany
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework
8.5.3.3. Competitive insights
8.5.3.4. Germany companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.5.4. France
8.5.4.1. Key country dynamics
8.5.4.2. Regulatory framework
8.5.4.3. Competitive insights
8.5.4.4. France companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.5.5. Italy
8.5.5.1. Key country dynamics
8.5.5.2. Regulatory framework
8.5.5.3. Competitive insights
8.5.5.4. Italy companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.5.6. Spain
8.5.6.1. Key country dynamics
8.5.6.2. Regulatory framework
8.5.6.3. Competitive insights
8.5.6.4. Spain companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.5.7. Norway
8.5.7.1. Key country dynamics
8.5.7.2. Regulatory framework
8.5.7.3. Competitive insights
8.5.7.4. Norway companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.5.8. Denmark
8.5.8.1. Key country dynamics
8.5.8.2. Regulatory framework
8.5.8.3. Competitive insights
8.5.8.4. Denmark companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.5.9. Sweden
8.5.9.1. Key country dynamics
8.5.9.2. Regulatory framework
8.5.9.3. Competitive insights
8.5.9.4. Sweden companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.6. Asia Pacific
8.6.1. Asia Pacific companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.6.2. Japan
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework
8.6.2.3. Competitive insights
8.6.2.4. Japan companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.6.3. China
8.6.3.1. Key country dynamics
8.6.3.2. Regulatory framework
8.6.3.3. Competitive insights
8.6.3.4. China companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.6.4. India
8.6.4.1. Key country dynamics
8.6.4.2. Regulatory framework
8.6.4.3. Competitive insights
8.6.4.4. India companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.6.5. South Korea
8.6.5.1. Key country dynamics
8.6.5.2. Regulatory framework
8.6.5.3. Competitive insights
8.6.5.4. South Korea companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.6.6. Australia
8.6.6.1. Key country dynamics
8.6.6.2. Regulatory framework
8.6.6.3. Competitive insights
8.6.6.4. Australia companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.6.7. Thailand
8.6.7.1. Key country dynamics
8.6.7.2. Regulatory framework
8.6.7.3. Competitive insights
8.6.7.4. Thailand companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.7. Latin America
8.7.1. Latin America companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.7.2. Brazil
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework
8.7.2.3. Competitive insights
8.7.2.4. Brazil companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.7.3. Argentina
8.7.3.1. Key country dynamics
8.7.3.2. Regulatory framework
8.7.3.3. Competitive insights
8.7.3.4. Argentina companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.8. MEA
8.8.1. MEA companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.8.2. South Africa
8.8.2.1. Key country dynamics
8.8.2.2. Regulatory framework
8.8.2.3. Competitive insights
8.8.2.4. South Africa companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.8.3. Saudi Arabia
8.8.3.1. Key country dynamics
8.8.3.2. Regulatory framework
8.8.3.3. Competitive insights
8.8.3.4. Saudi Arabia companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.8.4. UAE
8.8.4.1. Key country dynamics
8.8.4.2. Regulatory framework
8.8.4.3. Competitive insights
8.8.4.4. UAE companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.8.5. Kuwait
8.8.5.1. Key country dynamics
8.8.5.2. Regulatory framework
8.8.5.3. Competitive insights
8.8.5.4. Kuwait companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 9. COMPETITIVE LANDSCAPE
9.1. Participant Overview
9.2. Company Market Position Analysis
9.3. Company Categorization
9.4. Strategy Mapping
9.5. Company Profiles/Listing
9.5.1. Zoetis, Bayer AG
9.5.1.1. Overview
9.5.1.2. Financial performance
9.5.1.3. Product benchmarking
9.5.1.4. Strategic initiatives
9.5.2. Merck Animal Health
9.5.2.1. Overview
9.5.2.2. Financial performance
9.5.2.3. Product benchmarking
9.5.2.4. Strategic initiatives
9.5.3. Elanco, Norbrook
9.5.3.1. Overview
9.5.3.2. Financial performance
9.5.3.3. Product benchmarking
9.5.3.4. Strategic initiatives
9.5.4. Ceva Sante Animale
9.5.4.1. Overview
9.5.4.2. Financial performance
9.5.4.3. Product benchmarking
9.5.4.4. Strategic initiatives
9.5.5. Dechra Pharmaceuticals
9.5.5.1. Overview
9.5.5.2. Financial performance
9.5.5.3. Product benchmarking
9.5.5.4. Strategic initiatives
9.5.6. Boehringer Ingelheim International GmbH
9.5.6.1. Overview
9.5.6.2. Financial performance
9.5.6.3. Product benchmarking
9.5.6.4. Strategic initiatives
9.5.7. Daiichi Sankyo Co. Ltd.
9.5.7.1. Overview
9.5.7.2. Financial performance
9.5.7.3. Product benchmarking
9.5.7.4. Strategic initiatives
9.5.8. Assisi Animal Health
9.5.8.1. Overview
9.5.8.2. Financial performance
9.5.8.3. Product benchmarking
9.5.8.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Animal
1.2.2. Product
1.2.3. Route of Administration
1.2.4. End Use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
CHAPTER 3. COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
CHAPTER 4. COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET: ANIMAL BUSINESS ANALYSIS
4.1. Animal Market Share, 2024 & 2030
4.2. Animal Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Animal, 2018 to 2030 (USD Million)
4.4. Dogs
4.4.1. Dogs postoperative pain management therapeutics market, 2018 - 2030 (USD Million)
4.5. Cats
4.5.1. Cats postoperative pain management therapeutics market, 2018 - 2030 (USD Million)
4.6. Horses
4.6.1. Horses postoperative pain management therapeutics market, 2018 - 2030 (USD Million)
4.7. Other companions
4.7.1. Other companions postoperative pain management therapeutics market, 2018 - 2030 (USD Million)
CHAPTER 5. COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET: PRODUCT BUSINESS ANALYSIS
5.1. Product Market Share, 2024 & 2030
5.2. Product Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. NSAIDs
5.4.1. NSAIDs market, 2018 - 2030 (USD Million)
5.5. Anesthetics
5.5.1. Anesthetics market, 2018 - 2030 (USD Million)
5.6. Opioids
5.6.1. Opioids market, 2018 - 2030 (USD Million)
5.7. Others
5.7.1. Other market, 2018 - 2030 (USD Million)
CHAPTER 6. COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET: ROUTE OF ADMINISTRATION BUSINESS ANALYSIS
6.1. Route of Administration Market Share, 2024 & 2030
6.2. Route of Administration Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
6.4. Oral
6.4.1. Oral market, 2018 - 2030 (USD Million)
6.5. Injectable
6.5.1. Injectable market, 2018 - 2030 (USD Million)
CHAPTER 7. COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET: END USE BUSINESS ANALYSIS
7.1. End Use Market Share, 2024 & 2030
7.2. End Use Segment Dashboard
7.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
7.4. Retail
7.4.1. Retail market, 2018 - 2030 (USD Million)
7.5. E-commerce
7.5.1. E-commerce market, 2018 - 2030 (USD Million)
7.6. Veterinary hospitals & clinics
7.6.1. Veterinary hospitals & clinics market, 2018 - 2030 (USD Million)
CHAPTER 8. COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS BY ANIMAL, PRODUCT, ROUTE OF ADMINISTRATION, AND END USE
8.1. Regional Market Share Analysis, 2024 & 2030
8.2. Regional Market Dashboard
8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
8.4. North America
8.4.1. North America companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.4.2. U.S.
8.4.2.1. Key country dynamics
8.4.2.2. Regulatory framework
8.4.2.3. Competitive insights
8.4.2.4. U.S. companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.4.3. Canada
8.4.3.1. Key country dynamics
8.4.3.2. Regulatory framework
8.4.3.3. Competitive insights
8.4.3.4. Canada companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.4.4. Mexico
8.4.4.1. Key country dynamics
8.4.4.2. Regulatory framework
8.4.4.3. Competitive insights
8.4.4.4. Mexico companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.5. Europe
8.5.1. Europe companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.5.2. UK
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework
8.5.2.3. Competitive insights
8.5.2.4. UK companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.5.3. Germany
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework
8.5.3.3. Competitive insights
8.5.3.4. Germany companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.5.4. France
8.5.4.1. Key country dynamics
8.5.4.2. Regulatory framework
8.5.4.3. Competitive insights
8.5.4.4. France companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.5.5. Italy
8.5.5.1. Key country dynamics
8.5.5.2. Regulatory framework
8.5.5.3. Competitive insights
8.5.5.4. Italy companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.5.6. Spain
8.5.6.1. Key country dynamics
8.5.6.2. Regulatory framework
8.5.6.3. Competitive insights
8.5.6.4. Spain companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.5.7. Norway
8.5.7.1. Key country dynamics
8.5.7.2. Regulatory framework
8.5.7.3. Competitive insights
8.5.7.4. Norway companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.5.8. Denmark
8.5.8.1. Key country dynamics
8.5.8.2. Regulatory framework
8.5.8.3. Competitive insights
8.5.8.4. Denmark companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.5.9. Sweden
8.5.9.1. Key country dynamics
8.5.9.2. Regulatory framework
8.5.9.3. Competitive insights
8.5.9.4. Sweden companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.6. Asia Pacific
8.6.1. Asia Pacific companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.6.2. Japan
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework
8.6.2.3. Competitive insights
8.6.2.4. Japan companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.6.3. China
8.6.3.1. Key country dynamics
8.6.3.2. Regulatory framework
8.6.3.3. Competitive insights
8.6.3.4. China companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.6.4. India
8.6.4.1. Key country dynamics
8.6.4.2. Regulatory framework
8.6.4.3. Competitive insights
8.6.4.4. India companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.6.5. South Korea
8.6.5.1. Key country dynamics
8.6.5.2. Regulatory framework
8.6.5.3. Competitive insights
8.6.5.4. South Korea companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.6.6. Australia
8.6.6.1. Key country dynamics
8.6.6.2. Regulatory framework
8.6.6.3. Competitive insights
8.6.6.4. Australia companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.6.7. Thailand
8.6.7.1. Key country dynamics
8.6.7.2. Regulatory framework
8.6.7.3. Competitive insights
8.6.7.4. Thailand companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.7. Latin America
8.7.1. Latin America companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.7.2. Brazil
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework
8.7.2.3. Competitive insights
8.7.2.4. Brazil companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.7.3. Argentina
8.7.3.1. Key country dynamics
8.7.3.2. Regulatory framework
8.7.3.3. Competitive insights
8.7.3.4. Argentina companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.8. MEA
8.8.1. MEA companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.8.2. South Africa
8.8.2.1. Key country dynamics
8.8.2.2. Regulatory framework
8.8.2.3. Competitive insights
8.8.2.4. South Africa companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.8.3. Saudi Arabia
8.8.3.1. Key country dynamics
8.8.3.2. Regulatory framework
8.8.3.3. Competitive insights
8.8.3.4. Saudi Arabia companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.8.4. UAE
8.8.4.1. Key country dynamics
8.8.4.2. Regulatory framework
8.8.4.3. Competitive insights
8.8.4.4. UAE companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.8.5. Kuwait
8.8.5.1. Key country dynamics
8.8.5.2. Regulatory framework
8.8.5.3. Competitive insights
8.8.5.4. Kuwait companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 9. COMPETITIVE LANDSCAPE
9.1. Participant Overview
9.2. Company Market Position Analysis
9.3. Company Categorization
9.4. Strategy Mapping
9.5. Company Profiles/Listing
9.5.1. Zoetis, Bayer AG
9.5.1.1. Overview
9.5.1.2. Financial performance
9.5.1.3. Product benchmarking
9.5.1.4. Strategic initiatives
9.5.2. Merck Animal Health
9.5.2.1. Overview
9.5.2.2. Financial performance
9.5.2.3. Product benchmarking
9.5.2.4. Strategic initiatives
9.5.3. Elanco, Norbrook
9.5.3.1. Overview
9.5.3.2. Financial performance
9.5.3.3. Product benchmarking
9.5.3.4. Strategic initiatives
9.5.4. Ceva Sante Animale
9.5.4.1. Overview
9.5.4.2. Financial performance
9.5.4.3. Product benchmarking
9.5.4.4. Strategic initiatives
9.5.5. Dechra Pharmaceuticals
9.5.5.1. Overview
9.5.5.2. Financial performance
9.5.5.3. Product benchmarking
9.5.5.4. Strategic initiatives
9.5.6. Boehringer Ingelheim International GmbH
9.5.6.1. Overview
9.5.6.2. Financial performance
9.5.6.3. Product benchmarking
9.5.6.4. Strategic initiatives
9.5.7. Daiichi Sankyo Co. Ltd.
9.5.7.1. Overview
9.5.7.2. Financial performance
9.5.7.3. Product benchmarking
9.5.7.4. Strategic initiatives
9.5.8. Assisi Animal Health
9.5.8.1. Overview
9.5.8.2. Financial performance
9.5.8.3. Product benchmarking
9.5.8.4. Strategic initiatives
